AbCellera Biologics Inc. (ABCL) vs IDEAYA Biosciences, Inc. (IDYA)
A side-by-side comparison of AbCellera Biologics Inc. and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.79HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
IDYA
IDEAYA Biosciences, Inc.
$37.33HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — ABCL vs IDYA
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)IDYA +132.1% (+15.1%/yr)IDYA compounded faster over this window
Log scale — wide-divergence pair
ABCL IDYA
ABCL vs IDYA: by the numbers
- •ABCL is the larger company ($4.21B vs $3.55B market cap).
- •Both run net losses; IDYA's is the smaller (-74.75% vs -248.83% net margin).
- •IDYA grew revenue faster over the past five years (45.80% vs -31.78% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | IDYA |
|---|---|---|
| P/S ratio | 63.64 | 15.16 |
| P/B ratio | 4.70 | 2.96 |
Profitability
| Metric | ABCL | IDYA |
|---|---|---|
| Gross margin | 61.64% | -43.89% |
| Operating margin | -288.98% | -72.84% |
| Net margin | -248.83% | -74.75% |
| ROE | -18.38% | -14.60% |
| ROIC | -17.95% | -17.68% |
Growth (annualized)
| Metric | ABCL | IDYA |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | 45.80% |
| Total return CAGR (5Y) | -3.57% | 7.32% |
Frequently asked
- Which has grown faster, ABCL or IDYA?
- Over the past five years, IDYA grew revenue faster — ABCL at a -31.78% CAGR versus IDYA at 45.80%.
- How have ABCL and IDYA total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbCellera Biologics ROEIDEAYA Biosciences ROEAbCellera Biologics operating marginIDEAYA Biosciences operating marginAbCellera Biologics revenue growthIDEAYA Biosciences revenue growthAbCellera Biologics free cash flowIDEAYA Biosciences free cash flow
AbCellera Biologics & IDEAYA Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.